down arrow

Dishman Carbogen

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE385W01011
  • NSEID: DCAL
  • BSEID: 540701
INR
203.95
14.25 (7.51%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.41 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

195.00207.00

52 Week

132.75307.80
Valuation
Technical
Day's Volume

CASH

7.41 lacs (150.25%) Volume

Shareholding (Dec 2024)

FII

8.75%

Held by 59 FIIs

DII

1.42%

Held by 3 DIIs

Promoter

59.32%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -22.30% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.44
  • The company has been able to generate a Return on Equity (avg) of 0.25% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 3,198 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.36

stock-summary
Return on Equity

-2.84%

stock-summary
Price to Book

0.52

Revenue and Profits (1 Year):
Net Sales:
682 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
10.9%
0%
10.9%
1 Year
-15.79%
0%
-15.79%
2 Years
55.27%
0%
55.27%
3 Years
8.31%
0%
8.31%
4 Years
68.62%
0%
68.62%
5 Years
198.39%
0%
198.39%

Latest dividend: 0.2 per share ex-dividend date: Sep-12-2019

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.17%
EBIT Growth (5y)
-22.30%
EBIT to Interest (avg)
0.44
Debt to EBITDA (avg)
5.87
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.30
Tax Ratio
90.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.17%
ROCE (avg)
0.54%
ROE (avg)
0.25%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
0.52
EV to EBIT
63.89
EV to EBITDA
13.37
EV to Capital Employed
0.65
EV to Sales
1.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.36%
ROE (Latest)
-2.84%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (1.22%)

FIIs

Held by 59 FIIs (8.75%)

Promoter with highest holding

Adimans Technologies Llp (59.32%)

Highest Public shareholder

Mukul Mahavir Agrawal (5.5%)

Individual Investors Holdings

26.22%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 4.80% vs 1.77% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 107.76% vs -226.98% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "682.34",
          "val2": "651.09",
          "chgp": "4.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "140.13",
          "val2": "41.11",
          "chgp": "240.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "48.78",
          "val2": "33.08",
          "chgp": "47.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.04",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.63",
          "val2": "-59.63",
          "chgp": "107.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.54%",
          "val2": "6.31%",
          "chgp": "14.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.22% vs 13.46% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -86.11% vs -295.70% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,312.82",
          "val2": "1,309.97",
          "chgp": "0.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "176.12",
          "val2": "182.71",
          "chgp": "-3.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "68.56",
          "val2": "55.94",
          "chgp": "22.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.40",
          "val2": "-3.05",
          "chgp": "-175.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-44.48",
          "val2": "-23.90",
          "chgp": "-86.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.42%",
          "val2": "13.95%",
          "chgp": "-0.53%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 1.74% vs 9.29% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 52.29% vs -304.13% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,995.16",
          "val2": "1,961.06",
          "chgp": "1.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "316.25",
          "val2": "223.82",
          "chgp": "41.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "117.34",
          "val2": "89.02",
          "chgp": "31.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.36",
          "val2": "-3.05",
          "chgp": "-108.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-39.85",
          "val2": "-83.53",
          "chgp": "52.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.85%",
          "val2": "11.41%",
          "chgp": "4.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 8.41% vs 12.72% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -414.93% vs -265.46% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,615.77",
          "val2": "2,412.92",
          "chgp": "8.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "286.50",
          "val2": "332.20",
          "chgp": "-13.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "119.97",
          "val2": "85.69",
          "chgp": "40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.14",
          "val2": "-48.15",
          "chgp": "87.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-153.45",
          "val2": "-29.80",
          "chgp": "-414.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.95%",
          "val2": "13.77%",
          "chgp": "-2.82%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
682.34
651.09
4.80%
Operating Profit (PBDIT) excl Other Income
140.13
41.11
240.87%
Interest
48.78
33.08
47.46%
Exceptional Items
2.04
0.00
Consolidate Net Profit
4.63
-59.63
107.76%
Operating Profit Margin (Excl OI)
20.54%
6.31%
14.23%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 4.80% vs 1.77% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 107.76% vs -226.98% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,312.82
1,309.97
0.22%
Operating Profit (PBDIT) excl Other Income
176.12
182.71
-3.61%
Interest
68.56
55.94
22.56%
Exceptional Items
-8.40
-3.05
-175.41%
Consolidate Net Profit
-44.48
-23.90
-86.11%
Operating Profit Margin (Excl OI)
13.42%
13.95%
-0.53%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 0.22% vs 13.46% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -86.11% vs -295.70% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,995.16
1,961.06
1.74%
Operating Profit (PBDIT) excl Other Income
316.25
223.82
41.30%
Interest
117.34
89.02
31.81%
Exceptional Items
-6.36
-3.05
-108.52%
Consolidate Net Profit
-39.85
-83.53
52.29%
Operating Profit Margin (Excl OI)
15.85%
11.41%
4.44%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 1.74% vs 9.29% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 52.29% vs -304.13% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2,615.77
2,412.92
8.41%
Operating Profit (PBDIT) excl Other Income
286.50
332.20
-13.76%
Interest
119.97
85.69
40.00%
Exceptional Items
-6.14
-48.15
87.25%
Consolidate Net Profit
-153.45
-29.80
-414.93%
Operating Profit Margin (Excl OI)
10.95%
13.77%
-2.82%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 8.41% vs 12.72% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -414.93% vs -265.46% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Dishman Carbogen Amcis Ltd stock-summary
stock-summary
Dishman Carbogen Amcis Ltd
Small Cap
Pharmaceuticals & Drugs
Dishman Carbogen Amcis Limited was formerly incorporated as Carbogen Amcis (India) Limited on July 17, 2007. The Company name later on was changed to Dishman Carbogen Amcis Limited effective from 27 March 2017. The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
Company Coordinates stock-summary
Company Details
Dishman Corporate House, Iscon-Bopal Road Ambli Ahmedabad Gujarat : 380058
stock-summary
Tel: 91-2717-400102/124
stock-summary
htts://imdcal.com
stock-summary
grievance@dishmangroup.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."